Mid and small-cap stocks are outperforming, driving activity in stock futures. Analysts highlight GE Vernova T&D India, CAMS, Suzlon Energy...

Indian companies show strong recovery. Over 50 firms moved from losses to profits in the March quarter. This turnaround happened despite ma...

The Nifty Midcap 100 index reached a record high for the fourth consecutive session, driven by strong corporate earnings and promising grow...

Indian equity benchmarks extended gains for a third consecutive session as strong buying in banking, financial, energy and auto stocks lift...

Aluminium prices remain elevated amid Middle East tensions and tight global supply, with sentiment supported by structural shortages. Analy...

Indian equity markets fell for a fourth straight session as rising crude oil prices, geopolitical tensions, FII selling, and a record-low r...

Analysts are identifying stock-specific opportunities for May following April's short-covering rally. Bullish bets include Sun Pharma, Adan...

The week began on a positive note, supported by easing geopolitical tensions and steady progress in Q4 earnings, which lifted initial senti...

Crude oil futures fell sharply on Friday from 4-year highs after Iran signalled a proposal to resume negotiations with the U.S., though pri...

Indian stock markets ended a three-day losing streak with a gain of 0.8 percent on Monday. This rise followed positive movements in Asian m...

Markets may remain volatile amid key triggers this week, including the Fed policy decision, Q4 earnings and geopolitical tensions. Technica...

Religare institutional shareholders have sought ouster of the company board on grounds of mismanagement and oppression of minority sharehol...

Declining business from its largest customer, Hewlett-Packard, is back to haunt mid-sized technology services company MphasiS.

The stock of Hexaware gained 6.1% on Monday, its highest daily gain in a month since its quarterly results on July 19.

Religare maintained a ‘buy’ recommendation on Emami on back of strong volume growth and reasonable valuations.

Religare Institutional Research has maintained ‘buy’ on Ambuja Cements and raised its target price to Rs 240 from Rs 230 earlier.

Private equity firm Milestone Religare Investment Advisors has acquired about 5% stake in rating agency Credit Analysis & Research (CARE) f...